Printer friendly version Share

News Release

Muscle, skin and gastrointestinal problems cause a quarter of patients with heart disease and strokes to stop treatment in HPS2-THRIVE trial

25 February 2013 European Society of Cardiology (ESC)

Please login or register to view articles older than 3 months

New Norwegian logo eNEWS6 expertsvar 2015 FNSF ad Elhuyar with Basque Cambridge blue millet Facebook 2015